Jefferies analyst Brian Tanquilut raised the firm’s price target on RadNet (RDNT) to $100 from $82 and keeps a Buy rating on the shares. Ongoing strength in broader healthcare utilization, along with ...
Barclays raised the firm’s price target on RadNet (RDNT) to $85 from $79 and keeps an Overweight rating on the shares. The firm walked away from the RSNA Conference with a greater appreciation for the ...